Physician

James Anthony Stefater, MD, PHD

According to 2025 Medicare claims, James Stefater, MD, PHD (NPI: 1427491000) practices ophthalmology in the Boston, MA market, with the plurality of this provider's patient population coming from Norfolk, MA. This provider's primary affiliated billing organization is OPHTHALMIC CONSULTANTS OF BOSTON, INC. (NPI: 1932146594; TIN: 04-2500346) and primary practice location at 02189-3110. Stefater is affiliated with the Mass General Brigham ACO, LLC (ACO ID: A4641), participating under the MSSP model.

Stefater's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 989 traditional Medicare patients, billed 23,101 HCPCS/CPT codes, and received $2,303,708 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 319 prescription claims across 112 beneficiaries totaling $13,889 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 11 records totaling $3,536. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $11,475 to $2,303,708. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $5,228 and ending at $13,889. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	126	147	$11,475
2018	195	253	$28,225
2019	266	1,013	$159,437
2020	562	4,064	$627,274
2021	1,295	10,566	$2,075,079
2022	795	8,343	$1,466,082
2023	787	11,518	$1,658,989
2024	989	23,101	$2,303,708

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	53	95	$5,228
2016	25	35	$1,872
2017	141	393	$29,483
2018	131	317	$19,850
2019	97	232	$13,471
2020	107	286	$10,715
2021	126	408	$22,413
2022	119	390	$14,122
2023	102	357	$11,357
2024	112	319	$13,889

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
J0178	Injection, aflibercept, 1 mg	164	1,350	$656
67028	Injection of drug into eye	344	1,406	$103
92014	Established patient complete exam of visual system	725	928	$98
92012	Established patient problem focused exam of visual system	206	294	$70
92134	Imaging of retina	944	2,356	$33

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Prednisolone Acetate	Prednisolone Acetate	98	2,914	$3,487
Ketorolac Tromethamine	Ketorolac Tromethamine	26	951	$721
Ofloxacin	Ofloxacin	63	1,392	$675
Timolol Maleate	Timolol Maleate	22	1,722	$256
Latanoprost	Latanoprost	25	1,576	$251

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	0	$0	N/R
Research Payments	Reported research-related payment or transfer-of-value amount.	11	$3,536	Regeneron Pharmaceuticals, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for James Anthony Stefater, MD, PHD?

Tedicare shows public-source Medicare data for James Anthony Stefater, MD, PHD (NPI 1427491000), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does James Anthony Stefater, MD, PHD have ACO affiliation data?

James Anthony Stefater, MD, PHD is shown with ACO affiliation data for Mass General Brigham ACO, LLC (MSSP, ACO ID A4641).

What billing organization is linked to James Anthony Stefater, MD, PHD?

James Anthony Stefater, MD, PHD is linked to OPHTHALMIC CONSULTANTS OF BOSTON, INC. (billing NPI 1932146594) in the available physician profile data.

Does James Anthony Stefater, MD, PHD have Open Payments data?

James Anthony Stefater, MD, PHD has 11 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.